Arca
Skip to content

Cardiac surgery

Drug research and approvals for cardiac surgery: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 524 studies of cardiac surgery are recruiting on ClinicalTrials.gov, Health Canada has authorized 23 drug trials for it since 2013, FDA has 0 approved and 1 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 524
  • Trials authorized in Canada: 23
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting Now

Newest start dates first, of 524 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 23; search them all in Canada trials
Feb 7, 2025Auto-plts: the effectiveness of autologous, cold-stored platelets collected 7-10 days before cardi-ac surgery for avoidance of allogeneic transfusions: a…AUTOLOGOUS COLD-STORED APHERESIS PLATELETSDR. KEYVAN KARKOUTIOngoing
Jan 22, 2025Phase 3, double-blind, placebo-controlled, multicentre study on the efficacy and safety of human plasma derived antithrombin (atenativ) in heparin-resistant…ATENATIVOCTAPHARMA AGPending
Apr 12, 2024A phase 2b, randomized, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy on renal function, and safety, of…RMC-035GUARD THERAPEUTICS INTERNATIONAL ABOngoing
Apr 11, 2024A randomized, multi-centric, placebo-controlled, participant and investigator-blinded study to evaluate the safety, tolerability and efficacy of tin816 in…TIN816Novartis Pharmaceuticals CorporationOngoing
Feb 8, 2023A clinical comparison of cold-stored and room temperaturestored allogeneic platelet transfusions in bleeding adult cardiac surgery patients ¿ a randomized…COLD-STORED PLATELETSDR. KEYVAN KARKOUTIPending
Dec 14, 2022Artemis: ravulizumab to protect patients with chronic kidney disease (ckd) from cardiac surgery associated acute kidney injury (csa-aki) and subsequent major…ULTOMIRISAstraZeneca Pharmaceuticals LPOngoing
Jun 23, 2022Factor replacement in surgery - four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgical patients (¿fares-ii¿ study)OCTAPLEXOCTAPHARMA AGOngoing
Jan 11, 2022A phase 2, randomized, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of rmc-035 in subjects at…RMC-035 (RECOMBINANT HUMAN ALPHA-1-MICROGLOBULIN, ROSGARD, B125)GUARD THERAPEUTICS INTERNATIONAL ABOngoing
Dec 29, 2021The combined use of inhaled epoprostenol and milrinone to prevent a separation of difficult extracorporeal circulation during heart surgery: double-blind…EPOPROSTENOL / MILRINONEINSTITUT DE CARDIOLOGIE DE MTLPending
Jun 28, 2021A phase 2, double-blind, randomized, placebo-controlled study to evaluate the effect of rbt-1 on preconditioning response biomarkers in subjects undergoing…RBT-1 (IRON SUCROSE / STANNOUS PROTOPORPHYRIN)RENIBUS THERAPEUTICS, INC.Closed

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Nov 8, 2022Nitric Oxideto selectively reduce pulmonary arterial pressures in patients at elevated risk for developing hemodynamically unstable pulmonary…Keenova Therapeutics Ireland LimitedDesignated

Medicines Authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Sep 1, 2010Brinavessvernakalant hydrochlorideAdvanz Pharma LimitedEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.